Concepedia

Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials

Koji Sasaki, Sara S. Strom, Susan O’Brien, Elias Jabbour, Farhad Ravandi, Marina Konopleva, Gautam Borthakur, Naveen Pemmaraju, Naval Daver, Preetesh Jain,

The Lancet Haematology · 2015 · 313 citations · 35 references

Open access

Concepts

MedicineOncologyPharmacologyHematologic OncologyCancer Survival AnalysisHematologic MalignanciesHematologic Malignancy TherapyTyrosine Kinase InhibitorsChronic LeukemiasChronic Myeloid Leukemia TherapyJak InhibitorsRelative SurvivalRelative Survival AnalysisRelative Survival EstimationRelative Survival HazardTyrosine Kinase Inhibitor Therapy

References

35

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Brian Druker, François Guilhot, Stephen G. O’Brien et al. · New England Journal of Medicine · 2006 · 3.5K citations · Full text

Medicine, Hematology, Oncology +13

The relative survival rate: a statistical methodology.

Fred Ederer, Lillian M. Axtell, Stephen J. Cutler · PubMed · 1961 · 1.2K citations

Public Health, Biostatistics, Epidemiologic Methods +13

National Vital Statistics Reports NCHS.pdf

Dl Hoyert · Medical Entomology and Zoology · 2012 · 984 citations

Public Health, Demography, Epidemiology +10

United States Life Tables, 2017.

PubMed · 2019 · 805 citations

Social Sciences, Demography, Population Health Sciences +17

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, Hagop M. Kantarjian, Neil P. Shah et al. · New England Journal of Medicine · 2012 · 770 citations · Full text

Medicine, Oncology, Pharmacology +13